Abstract
Psychiatric genetics lies at the confluence of several turbulent streams in social policy. It increasingly involves the tools of molecular genetics, one of the fastest evolving areas of modern science; it taps into the ethics of genetic research, particularly the special aspects of family studies; and it deals with clinical conditions that by definition hinder normal mental functions, thus complicating the process by which individuals agree to participate in research. The symptoms of psychiatric conditions are behavioral, and the study of how genes influence behavior has long been attended by controversy. As historian Daniel Kevles noted, “In its ongoing fascination with questions of behavior, human genetics will undoubtedly yield information that may be wrong, or socially volatile, or, if the history of eugenic science is any guide, both” (Kevles & Hood, 1992).
Keywords
- Cystic Fibrosis
- Federal Government
- Government Printing
- Chronic Granulomatous Disease
- Behavioral Research
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Identify the requirements for informed consent to participation in biomedical and behavioral research ... by the institutionalized mentally infirm ... to determine the nature of the consent obtained from such persons or their legal representatives before such persons were involved in such research; the adequacy of the information given them respecting the nature and purpose of the research, procedures to be used, risks and discomforts, anticipated benefits from the research, and other matters necessary for informed consent; and the competence and the freedom of the persons to make a choice for or against involvement in such research. [National Commission, 1978d]
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, M. B. (Ed.). (1990). The wellborn science: Eugenics in Germany, France, Brazil, and Russia. London: Oxford University Press.
Advisory Committee on Human Radiation Experiments. (Release date copy, October 3, 1995). Final report. Page numbers may change from final report to be made available as Stock Number 061-000-00-848-9 from the U.S. Government Printing Office, Washington, DC.
Andrews, L. B. (1993, December). Testing and counseling for cystic fibrosis mutations: An independent contractor report on interim findings. Working Group on Ethical, Legal, and Social Implications of Genome Research.
Andrews, L. B., Fullarton, J. E., Holtzman, N. A., & Motulsky, A. G. (Ed.). (1994). Assessing genetic risks: Implications for health and social policy (pp. 9–10, 106). Washington, DC: National Academy Press.
Anonymous. (1994). NIH grants explore issues related to genetic testing for cancer risk. Human Genome News, 6(November), 15.
Beeson, D. (1993, September 9). Presentation to the working group. Working Group on Ethical, Legal, and Social Implications of Human Genome Research.
Botstein, D., White, R. L., Skolnick, M., & Davis, R. W. (1980). Construction of a genetic linkage map in man using restriction fragment length polymorphisms. American Journal of Human Genetics, 32, 314–331.
Caskey, C. T., Kaback, M. M., & Beaudet, A. L. (1990). The American Society of Human Genetics statement on cystic fibrosis screening. American Journal of Human Genetics, 46, 393.
Cavenee, W. K., Hansen, M. F., Nordernskjold, M., et al. (1985). Genetic origin of mutations predisposing to retinoblastoma. Science, 228, 501–503.
Childress, J. F. (1991). Deliberations of the Human Fetal Tissue Transplantation Research Panel. In K. E. Hanna (Ed.), Biomedical politics (pp. 215–248). Washington, DC: National Academy Press.
Code of Federal Regulations, Part 46—Protection of Human Subjects, revised as of March 8, 1983, reprinted July 31, 1989. Code of Federal Regulations, Title 45, Section 46; available through the Office of Protection from Research Risks, National Institutes of Health, July 31, 1989.
Cook-Deegan, R. M. (1994). A new social contract. In The gene wars: Science, politics, and the human genome (pp. 243–246). New York: Norton.
Dickens, B. M. (1990). Substitute consent to participation of persons with Alzheimer’s disease in medical research: Legal issues. In J. M. Berg, H. Karlinsky, & F. Lowy (Eds.), Alzheimer’s disease research: Ethical and legal issues (pp. 76–90). Toronto: Carswell.
Faden, R. R., & Beauchamp, T. L. (1986). A history and theory of informed consent. London: Oxford University Press.
Fink, L. (1990, April 3). Summary: First Workshop of the Joint Working Group on the Ethical, Legal, and Social Issues Related to Mapping and Sequencing the Human Genome. National Center for Human Genome Research.
Frankel, M. S., & Teich, A. H. (Eds.). (1993). Ethical and legal issues in pedigree research. Washington, DC: American Association for the Advancement of Science.
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert D. M., & Dryja, T. P. (1986). A human DNA segment with properties of the gene that prediposes to retinoblastoma and osteosarcoma. Nature, 323, 643–646.
Glass, K. C., & Somerville, M. A. (1990). Informed consent to medical research on persons with Alzheimer’s disease: Ethical and legal parameters. In J. M. Berg, H. Karlinsky, & F. Lowy (Eds.), Alzheimer’s disease research: Ethical and legal issues (pp. 30–59). Toronto: Carswell.
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkind, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y., Young, A. M., Shoulson, I., Bonilla, E., & Martin, J. B. (1983). A polymorphic DNA marker genetically linked to Huntington’s disease. Nature, 306, 234–238.
Huntington’s Disease Collaborative Research Group, Marcy E. MacDonald, et al. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Hunting-ton’s disease chromosomes. Cell, 72, 971–983.
Jonas, H. (1969). Philosophical reflections on experimenting with human subjects. In P. Freund (Ed.), Experimentation with human subjects. New York: George Braziller.
Kapp, M. B. (1994). Proxy decision making in Alzheimer disease research: Durable powers of attorney, guardianship and other alternatives. Alzheimer Disease and Associated Disorders, 8(Suppl. 4), 28–37.
Karlinsky, H., & Lennox, A. (1990). Assessment of competency of persons with Alzheimer’s disease to provide consent for research. In J. M. Berg, H. Karlinsky, & F. Lowy (Eds.), Alzheimer’s disease research: Ethical and legal issues (pp. 76–90). Toronto: Carswell.
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989). Identification of the cystic fibrosis gene: Genetic analysis. Science, 245, 1073–1080.
Kevles, D. J. (1985). In the name of eugenics. Berkeley: University of California Press.
Kevles, D. J., & Hood, L. (1992). In D. J. Kevles & L. Hood (Eds.), The code of codes: Scientific and social issues in the Human Genome Project (pp. 300–328). Cambridge, MA: Harvard University Press.
Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., & Kunkel, L. M. (1987). Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell, 50, 509–517.
Krimsky, S. (1982). Genetic alchemy: The social history of the recombinant DNA controversy. Cambridge, MA: MIT Press.
Lawson, E. (1991, November 1). Personal notes from Cystic Fibrosis Studies Consortium Planning Meeting. Institute of Medicine.
Lee, W.-H., Bookstein, R., Hong, F., Young, L.-J., Shew, J.-Y., & Lee, E. Y.-H. P. (1987). Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science, 235, 1394–1399.
Levi, J. (1991). Unproven AIDS therapies: The Food and Drug Administration and ddI. In K. E. Hanna (Ed.), Biomedical politics (pp. 9–37). Washington, DC: National Academy Press.
Li, F. P. (1992). Draft Recommendations on Predictive Testing for Germ Line p53 Mutations among Healthy Individuals. Presented to ELSI Working Group, February 10,1992. Dana Färber Cancer Institute, Boston, January 31, 1992.
Lifton, R. J. (1986). The Nazi doctors. New York: Basic Books.
Marson, D. C., Schmitt, F. A., Ingram, K. K., & Harrell, L. (1994). Determining the competency of Alzheimer patients to consent to treatment and research. Alzheimer Disease and Associated Disorders, 8(Suppl. 4), 5–18.
Melnick, V. L., & Dubler, N. N. (Eds.). (1985). Alzheimer’s dementia: Dilemmas in clinical research. Clifton, NJ: Humana Press.
National Center for Human Genome Research. (1990, October 8). NIH Collaboration Launches Research on Education and Counseling Related to Genetic Tests. Press release: Human Genome Project Progress. National Institutes of Health.
National Center for Human Genome Research, National Center for Nursing Research, National Institute of Child Health and Human Development and National Institute of Diabetes and Digestive and Kidney Diseases. (1991). RFA-HG-91-01. Studies of testing and counseling for cystic fibrosis mutations. NIH Guide to Grants and Contracts, 20(5 April), 5-6.
National Center for Human Genome Research. (1994). RFA: HG-94-01: Studies of genetic testing and counseling for heritable breast, ovarian and colon cancer risks. NIH Guide to Grants and Contracts, 23(4 February), 3-5.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, U.S. Department of Health, Education and Welfare. (1975). Research on the fetus. Washington, DC: U.S. Government Printing Office.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, U.S. Department of Health, Education and Welfare. (1976). Research involving prisoners. Washington, DC: U.S. Government Printing Office.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, U.S. Department of Health, Education and Welfare. (1977a). Disclosure of research information under the Freedom of Information Act. Washington, DC: U.S. Government Printing Office.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, U.S. Department of Health, Education and Welfare. (1977b). Psychosurgery. Washington, DC: U.S. Government Printing Office.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, U.S. Department of Health, Education and Welfare. (1977c). Research involving children. Washington, DC: U.S. Government Printing Office.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, U.S. Department of Health, Education and Welfare. (1978a). The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research. Washington, DC: U.S. Government Printing Office. Reprinted in Federal Register, April 19, 1979.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, U.S. Department of Health, Education and Welfare. (1978b). Ethical guidelines for the delivery of health services by DHEW. Washington, DC: U.S. Government Printing Office.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, U.S. Department of Health, Education and Welfare. (1978c). Institutional review boards. Washington, DC: U.S. Government Printing Office.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1978d). Research involving those institutionalized as mentally infirm (DHEW Publication No. (OS) 78-0006). U.S. Department of Health, Education and Welfare.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, U.S. Department of Health, Education and Welfare. (1978e). Special study: Implications of advances in biomedical and behavioral research. Washington, DC: U.S. Government Printing Office.
National Research Council. (1988). Mapping and sequencing the human genome. Washington, DC: National Academy Press.
NCHGR Program Advisory Committee on the Human Genome. (1990, December 3). Resolution. National Center for Human Genome Research, National Institutes of Health.
NIH Workshop on Population Screening for the Cystic Fibrosis Gene. (1990, March 6). Statement. National Institutes of Health.
Office of Protection from Research Risks. (1993). Protecting human research subjects: Institutional review board guidebook. Bethesda: National Institutes of Health, U.S. Department of Health and Human Services.
Office of Science and Technology Policy. (1994, August 12). Federal Register.
Office of the Press Secretary, The White House. (1995, October 3). Protection of human research subjects and creation of National Bioethics Advisory Commission.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1981a). Defining death. Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1981b). Protecting human subjects. Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1982a). Compenasating research injury. Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1982b). Making health care decisions (with Vol. 2 and 3 appendices). Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1982c). Splicing life. Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1982d). Whistleblowing in biomedical research. Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1983a). Deciding to forego life-sustaining treatment. Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1983b). Implementing human research regulations. Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1983c). Screening and counseling for genetic conditions. Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1983d). Securing access to health care. Washington, DC: U.S. Government Printing Office.
President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. (1983e). Summing up. Washington, DC: U.S. Government Printing Office.
Proctor, R. N. (1988). Racial hygiene: Medicine under the Nazis. Cambridge, MA: Harvard University Press.
Ramsey, P. (1970). The patient as person. New Haven, CT: Yale University Press.
Rich, D. P., Anderson, M. P., Gregory, R. J., Cheng, S. H., Paul, S., Jefferson, D. M., McCann, J. D., Klinger, K. W., Smith, A. E., & Welsh, M. J. (1990). Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature, 347, 358–363.
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., Drumm, M. L., Iannuzzi, M. C., Collins, F. S., & Tsui, L.-C., (1989). Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science, 245, 1066–1072.
Roberts, L. (1990). Cystic fibrosis pilot projects go begging. Science, 250, 1076–1077.
Roberts, L. (1993). Whither the ELSI Program? Hastings Center Report, 23(November-December), 5.
Rommens, J. M., Iannuzzi, M. C., et al., (1989). Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science, 245, 1059–1065.
Royer, B., Kunkel, L., Monaco, A., Goff, S., Newburger, P., Baehner, R., Cole, F., Curnutte, J., & Orkin, S. (1987). Cloning the gene for an inherited human disorder—chronic granulo-matous disease—on the basis of its chromosomal location. Nature, 322, 32–38.
Simpson, S. G. (1993). Bipolar mood disorder. In M. S. Frankel & A. H. Teich (Eds.), Ethical and legal issues in pedigree research (pp. 39–63). Washington, DC: American Association for the Advancement of Science.
Thomson, E., & Drell, D. (1995, February 6). Presentations to the ELSI Working Group on the NIH and DOE ELSI grant portfolios, respectively. Holiday Inn, Bethesda.
Tsui, L.-C., Buchwald, M., et al., (1985). Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science, 230, 1054–1057.
U.S. Congress. (1988, April). Mapping our genes—Genome projects: How big? How fast? Office of Technology Assessment (OTA-BA-373). Washington, DC: Government Printing Office; reprinted by Johns Hopkins University Press.
U.S. Congress (1993, June). Biomedical ethics in US public policy (OTA-BP-BBS-105). Background Paper. Office of Technology Assessment.
U.S. Department of Health, Education, and Welfare. (1978a). Proposed regulations on research involving those institutionalized as mentally disabled. Federal Register, 43(223), 53950–53956.
U.S. Department of Health, Education, and Welfare. (1978b). Protection of human subjects: Research involving those institutionalized as mentally infirm. Federal Register, 43(53), 11328–11358.
U.S. Senate. (1989, November 9). Human Genome Initiative. S. Hrg. 101-528. Subcommittee on Science, Technology and Space, Committee on Commerce, Science, and Transportation.
Wainwright, B. J., Scambler, P. J., Schmidtke, J., Watson, E. A., Law, H.-Y., Farrall, M., Cooke, H. J., Eiberg, H., & Williamson, R. (1985). Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature, 318, 384–385.
Watson, J. D. (1988, September 26). NIH Press Conference: Appointment of James D. Watson to Head NIH Office of Human Genome Research. Bethesda: National Center for Human Genome Research; also available from the National Reference Center for Bioethics Literature, Georgetown University.
Weisburd, D. E. (Ed.). (1994). The Journal, Vol. 5, No. 1. Sacramento: California Alliance for the Mentally Ill.
White House. (1994, December 2). Statement by the President on NIH Recommendation Regarding Human Embryo Research. US Newswire. White House Press Office.
White, R., Woodward, S., Leppert, M., O’Connell, P., Hoff, M., Herbst, J., Lalouel, J.-M., Dean, M., & Vande Woude, G. (1985). A closely linked genetic marker for cystic fibrosis. Nature, 318, 382–384.
Wilfond, B. S., Fost, N. (1990, November 9). Cystic fibrosis heterozygote detection: The introduction of genetic testing into clinical practice. Program in Medical Ethics, University of Wisconsin, presentation to ELSI Working Group. Revised versions of this paper were published in the Journal of the American Medical Association, 263, 2777–2783, 1991; and Milbank Quarterly, 70, 629-659, 1992.
Wilfond, B. S., & Nolan, K. (1993). National policy development for the clinical application of genetic diagnostic techniques. Journal of the American Medical Association, 270, 2948–2954.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cook-Deegan, R.M. (1996). Bioethics and the Federal Government. In: Hall, L.L. (eds) Genetics and Mental Illness. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0170-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0170-5_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0172-9
Online ISBN: 978-1-4899-0170-5
eBook Packages: Springer Book Archive